MRMD — Marimed Balance Sheet
0.000.00%
- $41.98m
- $111.87m
- $157.96m
- 58
- 96
- 26
- 63
Annual balance sheet for Marimed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.36 | 29.9 | 9.86 | 14.7 | 7.28 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 7.33 | 1.79 | 6.82 | 7.36 | 8.79 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 21 | 44.6 | 44.1 | 51.4 | 53.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 51 | 67.3 | 77.3 | 102 | 107 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 76.4 | 123 | 152 | 196 | 207 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 23.2 | 27.2 | 26.5 | 30.9 | 48.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 53 | 47.6 | 55.7 | 106 | 126 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 23.4 | 75.6 | 96.5 | 90.6 | 80.6 |
Total Liabilities & Shareholders' Equity | 76.4 | 123 | 152 | 196 | 207 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |